AXSM — Axsome Therapeutics Share News
0.000.00%
Last trade - 00:00- $7.51bn
- $7.40bn
- $638.50m
U.S. STOCKS ON THE MOVE-Inogen, VeriSign, Boeing
U.S. STOCKS ON THE MOVE-Artiva Biotherapeutics, Axsome Therapeutics, American Airlines
Axsome declines after mixed data from Alzheimer's-related drug
Axsome's Alzheimer's-related drug shows mixed results in late-stage studies (updated)
Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study
U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot
Axsome Therapeutics Inc reports results for the quarter - Earnings Summary
Brief: Axsome Therapeutics Q3 Net Income USD -64.602 Million
Brief: Axsome Therapeutics On September 30 Entered Into Fifth Amendment To Its Loan & Security Agreement Dated Sept 25, 2020
Brief: Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
U.S. RESEARCH ROUNDUP- Actinium Pharmaceuticals, Albemarle, ArcBest
Axsome Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Axsome Therapeutics Q2 Net Income USD -79.345 Million
Axsome Therapeutics Inc expected to post a loss of $1.33 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Affirm, Calavo Growers, Shoals Technologies
Axsome Therapeutics falls after Culper discloses short position
U.S. STOCKS ON THE MOVE-Spotify, Affirm, Calavo Growers
Axsome Therapeutics falls after Culper Research discloses short position
Brief: Culper Research Says Short On Axsome Therapeutics